Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study

W. Jongbloed; M.I. Kester; W.M. van der Flier; R. Veerhuis; P. Scheltens; M.A. Blankenstein; C.E. Teunissen

doi:10.1016/j.jalz.2012.01.004

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study

W. Jongbloed, M.I. Kester, W.M. van der Flier, R. Veerhuis, P. Scheltens, M.A. Blankenstein, C.E. Teunissen

Research output: Contribution to Journal › Article › Academic › peer-review

Abstract

Background: Multiplex assays such as xMAP have been proposed for the assessment of Alzheimer's disease (AD) biomarkers amyloid β 42 (Aβ

Original language	English
Pages (from-to)	276-283
Journal	Alzheimers & Dementia
Volume	9
Issue number	3
DOIs	https://doi.org/10.1016/j.jalz.2012.01.004
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jalz.2012.01.004

Cite this

@article{b9a24649430a462eb145eb8b67cc6b44,

title = "Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study",

abstract = "Background: Multiplex assays such as xMAP have been proposed for the assessment of Alzheimer's disease (AD) biomarkers amyloid β 42 (Aβ",

author = "W. Jongbloed and M.I. Kester and {van der Flier}, W.M. and R. Veerhuis and P. Scheltens and M.A. Blankenstein and C.E. Teunissen",

year = "2013",

doi = "10.1016/j.jalz.2012.01.004",

language = "English",

volume = "9",

pages = "276--283",

journal = "Alzheimers & Dementia",

issn = "1552-5260",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study

AU - Jongbloed, W.

AU - Kester, M.I.

AU - van der Flier, W.M.

AU - Veerhuis, R.

AU - Scheltens, P.

AU - Blankenstein, M.A.

AU - Teunissen, C.E.

PY - 2013

Y1 - 2013

N2 - Background: Multiplex assays such as xMAP have been proposed for the assessment of Alzheimer's disease (AD) biomarkers amyloid β 42 (Aβ

AB - Background: Multiplex assays such as xMAP have been proposed for the assessment of Alzheimer's disease (AD) biomarkers amyloid β 42 (Aβ

U2 - 10.1016/j.jalz.2012.01.004

DO - 10.1016/j.jalz.2012.01.004

M3 - Article

VL - 9

SP - 276

EP - 283

JO - Alzheimers & Dementia

JF - Alzheimers & Dementia

SN - 1552-5260

IS - 3

ER -

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this